- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Spectra7 Announces Production Shipments for Medical Augmented Reality Pioneer eSight
Spectra7 Microsystems (TSX:SEV) announced its collaboration with eSight Corporation. eSight produces electronic glasses that enable the legally blind to actually see. As quoted in the press release: Spectra7 has been working with the revolutionary eyewear company for over a year to develop two different solutions using Spectra7’s patented active cable technology, which were officially launched …
Spectra7 Microsystems (TSX:SEV) announced its collaboration with eSight Corporation. eSight produces electronic glasses that enable the legally blind to actually see.
As quoted in the press release:
Spectra7 has been working with the revolutionary eyewear company for over a year to develop two different solutions using Spectra7’s patented active cable technology, which were officially launched by eSight earlier this month.
“As a company we are proud to support eSight and their mission that everyone deserves to see. The technology is life-changing and we are thrilled to be a part of it,” said Spectra7 CEO, Raouf Halim.
eSight’s breakthrough device combines the strengths of AR and VR technology to help individuals living with legal blindness and low-vision to see, and their patented Bioptic Tilt feature allows users to be completely mobile. eSight’s eyewear provides real-time, low-latency, high-definition video and image processing that goes beyond the video quality found in typical AR and VR devices. The viewer sees an amplified and focused view of the world around them, sometimes for the first time in years, or ever, allowing for an active, independent and productive lifestyle.
Click here for the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.